MGI (688114): Discloses the progress of litigation involving the company and its subsidiaries
I'm LongbridgeAI, I can summarize articles.MGI (688114) announced on May 22 that its subsidiary, HuaDa XuFeng, received litigation materials from the High Court of England and Wales. The case has been filed but has not yet gone to trial. MGI, as the defendant, is facing an initial estimated claim amount of £10 million or more. The company is primarily engaged in the research and development and sales of gene sequencers
MGI (688114) announced on May 22 that its subsidiary, Hangzhou MGI Xufeng Technology Co., Ltd. (referred to as "MGI Xufeng"), recently received litigation materials including the "Application" with the case number HP-2024-000042 from the Commercial Court of the High Court of England and Wales.
Current stage of the litigation: The case has been filed but not yet heard; the status of the listed company: Defendant; amount involved: This case involves a monetary claim that has not yet been quantified. According to the plaintiff's claims, the preliminary estimated claim against the defendant is £10 million or more (total amount claimed against all defendants).
Information shows that MGI (688114) focuses on the innovative research and development and sales of life science tools centered around gene sequencers